Cancer
Multiple Myeloma
| Publication Date | October 2007 |
| Publisher | Informa Healthcare |
| Product Type | Book |
| Pages | 267 |
| ISBN Number | 978-1-4200-4510-9 |
| Product Code | IFH00125 |
Price
£105.00
approximately: $159 | €117
approximately: $159 | €117
Order above formats by FAX
Summary
Multiple Myeloma is the second most prevalent hematological malignancy, with over 55,000 new cases diagnosed each year. This exciting reference, edited by lauded authorities on the topic, stands as the only available reference to assemble, review, and synthesize the latest studies on translational therapies, and clearly explains the impact of molecular pathogenesis, biology, and prognostic factors on the diagnosis, prognosis, and individualization of treatment and the development of novel therapeutic options for patients with myeloma.
Contents
- Molecular Pathogenesis and Biology of Multiple Myeloma
- Molecular Biology, Cytogenetics and Gene Expression in Multiple Myeloma
- Molecular Mechanisms of Growth, Survival and Drug Resistance
- Animal Models in Multiple Myeloma- Challenges and Future Direction
- The Bone Marrow Microenvironment in Multiple Myeloma
- Myeloma Bone Disease
- Homing and Migration of Multiple Myeloma
- Novel Therapeutic Targets in Multiple Myeloma and The Bone Marrow Milieu
- Diagnostic and Therapeutic Options in Multiple Myeloma
- Monoclonal Gammopathy of Undetermined Significance
- Prognostic Factors and Classification in Multiple Myeloma
- Novel Options of Therapy in Newly Diagnosed Multiple Myeloma
- Novel Options of Therapy in Relapsed Multiple Myeloma
- High Dose Therapy in Multiple Myeloma
- Promising New Agents in Phase I and Ii Clinical Trials in Multiple Myeloma
- Immunotherapy in Multiple Myeloma
- Translational Therapeutic Options in Other Plasma Cell Dyscrasias
- Novel Options of Therapy in Primary Systemic Amyloidosis
- Novel Options of Therapy in Waldenstrom's Macroglobulinemia
